<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oral squamous cell carcinoma &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/oral-squamous-cell-carcinoma/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 20 Jan 2026 10:28:13 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Oral squamous cell carcinoma &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Astragalus Polysaccharide Boosts STM2457 in OSCC Therapy</title>
		<link>https://bioengineer.org/astragalus-polysaccharide-boosts-stm2457-in-oscc-therapy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 20 Jan 2026 10:27:47 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Astragalus polysaccharide]]></category>
		<category><![CDATA[Based on the content]]></category>
		<category><![CDATA[Combinatorial Cancer Treatment]]></category>
		<category><![CDATA[Combinatorial therapy]]></category>
		<category><![CDATA[Epitranscriptomics** * **Oral squamous cell carcinoma:** Makalenin temel odak noktası (OSCC). * **m6A methylation:** Ana hedef mekanizma ve STM2457'in etki alanı. * **Combinatorial]]></category>
		<category><![CDATA[here are 5 appropriate tags focusing on the key concepts: **Epitranscriptomic Therapy]]></category>
		<category><![CDATA[İçeriğe göre en uygun 5 etiket: **Oral squamous cell carcinoma]]></category>
		<category><![CDATA[m6A methylation]]></category>
		<category><![CDATA[m6A Methylation Inhibition]]></category>
		<category><![CDATA[Oral squamous cell carcinoma]]></category>
		<guid isPermaLink="false">https://bioengineer.org/astragalus-polysaccharide-boosts-stm2457-in-oscc-therapy/</guid>

					<description><![CDATA[In a groundbreaking advance poised to reshape the therapeutic landscape of oral squamous cell carcinoma (OSCC), recent research spearheaded by Wang X. has illuminated a compelling synergy between astragalus polysaccharide (APS) and STM2457, a novel m6A RNA methylation inhibitor. As OSCC remains a formidable oncological challenge due to its aggressive nature and often limited treatment [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318845</post-id>	</item>
		<item>
		<title>Unlocking Epigenetics: Breakthrough Insights into Oral Cancer Progression and Therapies</title>
		<link>https://bioengineer.org/unlocking-epigenetics-breakthrough-insights-into-oral-cancer-progression-and-therapies/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 07 May 2025 18:43:00 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Epigenetic therapies]]></category>
		<category><![CDATA[LSD1 inhibition]]></category>
		<category><![CDATA[Oral squamous cell carcinoma]]></category>
		<category><![CDATA[Preneoplastic intervention]]></category>
		<category><![CDATA[Tumor Immune Evasion]]></category>
		<guid isPermaLink="false">https://bioengineer.org/unlocking-epigenetics-breakthrough-insights-into-oral-cancer-progression-and-therapies/</guid>

					<description><![CDATA[Oral squamous cell carcinoma (OSCC) remains a formidable challenge within oncology, owing to its high prevalence and often late-stage diagnosis. Despite significant advances in cancer biology, the molecular events that propel preneoplastic lesions toward invasive OSCC have remained elusive, particularly regarding the epigenetic alterations that may serve as early triggers in tumorigenesis. A groundbreaking study [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">244049</post-id>	</item>
	</channel>
</rss>
